A multicenter, open-label phase II trial of secondline apatinib plus irinotecan in patients with advanced gastric cancer

被引：0
|
作者：
Peng, Jianjun
Li, Yong
Xiao, Jianjun
Liu, Huaqiang
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China
[2] Tradit Chinese Med Hosp Guangdong Prov, Guangzhou, Peoples R China
[3] Zhongshan City Peoples Hosp, Zhongshan, Peoples R China
[4] Cent Hosp Guangdong Prov Agr Reclamat, Zhanjiang, Guangdong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.287
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
287
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial
    Lan, Chunyan
    Shen, Jingxian
    Wang, Yin
    Li, Jundong
    Liu, Zhimin
    He, Mian
    Cao, Xinping
    Ling, Jiayu
    Huang, Jiaming
    Zheng, Min
    Zou, Guorong
    Yan, Haowen
    Liu, Qing
    Yang, Fan
    Wei, Wei
    Deng, Yanhong
    Xiong, Ying
    Huang, Xin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (34)
  • [2] Camrelizumab plus apatinib in patients with advanced cervical cancer: A multicenter, open-label, single-arm, phase II trial.
    Lan, Chunyan
    Huang, Xin
    Shen, Jing-Xian
    Wang, Yin
    Xiong, Ying
    Li, Jundong
    Cao, Xinping
    Deng, Yanhong
    He, Mian
    Zou, Guorong
    Wang, Xiaodi
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Apatinib plus camrelizumab in patients with advanced cervical cancer: A multicentre, open-label, single-arm, phase II trial
    Huang, X.
    Shen, J.
    Xiong, Y.
    Wang, Y.
    Cao, X.
    He, M.
    Zou, G.
    Deng, Y.
    Wang, X.
    Lan, C.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 43 - 43
  • [4] Camrelizumab (C) in combination with apatinib (A) in patients with advanced hepatocellular carcinoma (RESCUE): An open-label, multicenter, phase II trial
    Xu, J.
    Shen, J.
    Gu, S.
    Zhang, Y.
    Wu, L.
    Wu, J.
    Shao, G.
    Zhang, Y.
    Xu, L.
    Yin, T.
    Liu, J.
    Ren, Z.
    Xiong, J.
    Mao, X.
    Zhang, L.
    Yang, J.
    Li, L.
    Chen, X.
    Wang, Z.
    Wang, Q.
    ANNALS OF ONCOLOGY, 2020, 31 : S689 - S689
  • [5] An open-label, multicenter phase II trial of sunitinib for patients with chemorefractory metastatic gastric cancer.
    Moehler, M. H.
    Hartmann, J. T.
    Lordick, F.
    Al-Batran, S.
    Reimer, P.
    Trarbach, T.
    Ebert, M. P.
    Daum, S.
    Weihrauch, M.
    Galle, P. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Apatinib in Chinese patients with advanced hepatocellular carcinoma: A phase II randomized, open-label trial.
    Qin, Shukui
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] Camrelizumab plus apatinib combined with POF in patients with untreated advanced gastric cancer (UAGC): A singlecenter, open-label, single-arm, phase II trial (SYLT-017)
    Su, L.
    Zhao, S.
    Lin, P.
    Yin, Y.
    Lin, R.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1119 - S1120
  • [8] Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A for Nonrandomized, Open-label, Phase II Trial
    Xu, Jianming
    Shen, Jie
    Gu, Shanzhi
    Zhang, Yun
    Wu, Lihua
    Wu, Jian
    Shao, Guoliang
    Zhang, Yanqiao
    Xu, Li
    Yin, Tao
    Liu, Jingfeng
    Ren, Zhenggang
    Xiong, Jianping
    Mao, Xianhai
    Zhang, Ling
    Yang, Jiayin
    Li, Lequn
    Chen, Xiaoming
    Wang, Zhiming
    Gu, Kangsheng
    Chen, Xi
    Pan, Zhanyu
    Ma, Kuansheng
    Zhou, Xinmin
    Yu, Zujiang
    Li, Enxiao
    Yin, Guowen
    Zhang, Xiao
    Wang, Shuni
    Wang, Quanren
    CLINICAL CANCER RESEARCH, 2021, 27 (04) : 1003 - 1011
  • [9] Oxaliplatin and Irinotecan in advanced gastric cancer.: A multicenter phase II trial
    Woell, E.
    Eisterer, W.
    Hilbe, W.
    Kuehr, T.
    Gattringer, K.
    Greil, R.
    Zabernigg, A.
    Baldinger, C.
    Thaler, J.
    EJC SUPPLEMENTS, 2005, 3 (02): : 213 - 213
  • [10] An open-label, multicenter biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer
    Moehler, M.
    Mueller, A.
    Hartmann, J. T.
    Ebert, M.
    Al-Batran, S-E
    Reimer, P.
    Weihrauch, M.
    Lordick, F.
    Trarbach, T.
    Biesterfeld, S.
    Kabisch, M.
    Wachtlin, D.
    Galle, P. R.
    ONKOLOGIE, 2011, 34 : 103 - 103
12345